Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Directions
Current Status and Future Directions
$399.01
- Hardcover
226 pages
- Release Date
2 June 2008
Summary
Radiotherapy plays an integral role in Cancer treatment. Approximately 60% of Cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agents with radiotherapy is the latest cutting-edge extension in Cancer therapy for Radiation Oncologists.
Combining Targeted Biological Agents with Radiotherapy: Current Status and Future Dire…
Book Details
| ISBN-13: | 9781933864341 |
|---|---|
| ISBN-10: | 1933864346 |
| Author: | William Small |
| Publisher: | Demos Medical Publishing |
| Imprint: | Demos Medical Publishing |
| Format: | Hardcover |
| Number of Pages: | 226 |
| Release Date: | 2 June 2008 |
| Weight: | 594g |
| Dimensions: | 18mm x 178mm x 261mm |
| Series: | Springer Demos Medic |
You Can Find This Book In
What They're Saying
Critics Review
The book was written to ‘review both the basic science and current clinical status of combining targeted biological agents with radiotherapy’… The authors are experts in the field of molecular targeting and clinical trials… comprehensive reviews of current studies and planned studies… well written.–Doody’s Reviews
About The Author
William Small
William Small, Jr, MD is Professor of Radiation Oncology and Vice-Chairman of the Department of Radiation Oncology at Northwestern University. He is the Associate Medical Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and serves on the editorial board of the American Journal of Hematology/Oncology Review and Cancer News.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.